Cytokine activity of the isolated recombinant C-terminai domain of mammalian tyrosyl-tRNA synthetase (TyrRS) 1 which is homologous to a tumor-derived cytokine, endothelial and monocyte activating polypeptide has been studied.
Introduction.
Aminoacyl-t RNA synthetases (ARSases) of higher eukaryotes usually possess amino-and/or carboxy-terminal polypeptide extensions of catalytic enzyme core which are dispensable for their catalytic activities Il-4]. Tlve functions of these extensions are related to the complex organization of protein synthesis apparatus of multicellular organisms. For example, some mammalian ARSases have abilities to form a multi-tRNA synthetase complex which includes 9 ARSases and 3 other auxiliary protein components Il-3]. On other hand, these appended domains could be responsible for the polyanion binding properties of eukaryotic ARSases and compartmentalization of components of protein synthesis machinery on the ribosomes [4, 5] .
Recently the amino acid sequences of bovine and human TyrRS were determined [6, 7] , revealing a high sequence homology (51 % identity) between the C-terminal, non-catalytic domain of TyrRS and the novel cytokine-like molecule endothelial-monocyteactivating polypeptide (EMAP-2) [6] [7] [8] . Previously, we have shown , that bovine tyrosyl-tRNA synthetase (a 2 -dimer, 2 χ 59 kDa) could be isolated from bovine ©Al.
KORNELYUK, M. P. R. TAS1 A. U DUBROVSKY, J. C. MURRAY, 1999 liver both as the full-length protein and as a proteolytically-modified active enzyme form (2 χ χ 39 kDa), which lacks its C-terminal polypeptide extension [9, 10] . Both distinct molecular forms of TyrRS displayed the similar catalytic constants in tRNA aminoacylation reaction [9. 101. Moreover, the dispensable C-terminal polypeptide extension of bovine TyrRS revealed a significant contribution to the non-specific affinity of this enzyme for RNA [11] . A novel putative cytokine, EMAP-2, modulates a variety of properties of endothelial cells, monocytes and leukocytes in vitro, and induces an acute inflammatory reaction in vivo [12, 16] . Based on the sequence similarity of mammalian TyrRS C-domain and EMAP-2, we have forwarded the hypothesis thai the isolated C-domain may also display the cytokine activity, similar to EMAP-2 cytokine [8 ] . In order to verify this hypothesis we have cloned and expressed the isolated non-catalytic C-terminal domain of bovine TyrRS [17] .
In this work we have discovered several cytokinelike activities of the isolated C-domain of TyrRS in vitro which are compared with the properties of recombinant EMAP-2 cytokine.
Materials and Methods. Proteins isolation. Clo-ning and bacterial expression of the C-terminal domain of bovine TyrRS was performed as described earlier [17] . The BamHI cDNA fragment encoding residues D322-S528 of bovine TyrRS was cloned into the pET15h vector for bacterial expression and recombinant protein was expressed in BL21(DE3) Escherichia coli ceils harboring the pEYCD2 plasmid. The supernatant was loaded onto Ni-NTA column and 6His-tagged recombinant protein was eluted with 300 mM imidazole. Recombinant human EMAP-2 and proEMAP-2 were isolated and characterized as previously described [18 ] .
Monocyte chemotaxis: Freshly-isolated monocytes were then suspended in RPMI-1640 medium with 10 % foetal calf serum, at 2 χ IO 6 cells per ml. Solutions of proteins (TyrRS C-domain, 39 kDa TyrRS and EMAP-2) or chemotactic peptide, formylmethionyl-Ieucyl-phenyalanine (fMLP) (31 μΐ) at the indicated concentrations were placed in the bottom wells of ChemTx micro-chemotaxis plates (Neuro Probe, Inc.) in triplicate. The filter was placed on top of the solution in such a way as to provide fluid continuity between the upper and lower chambers. An aliquot of monocyte suspension (27 μΐ) was then placed on top of the filter above each well, and the plates incubated with lids on for 1.5 hr at 37 °С in air/5 % CO 2 . After incubation, cells binding to the membrane were fixed by the addition of 15 μΐ of ice-cold 20 % formaldehyde in phosphate-buffered saline, and those that had migrated to the underside of the membrane were counted with a haemocytometer.
Procoagulant activity assay. Human umbilical vein endothelial cells (HUVEC) were isolated essentially by the method of Jaffe et al. [19] . Confluent endothelial monolayers at passages 2 to 3 were used to assess tissue factor-dependent procoagulant activity [20 I . Coagulation was initiated by the addition of 100 μ\ of 30 mM CaCl 2 solution at 37 °С and the time for visible fibrin strand/gel formation was determined. Procoagulant activity of endothelial monolayers was expressed as tissue factor equivalents (TFE, pg/10 6 cells) [20] .
Results and Discussion. Purification of recombinant C-domain of TyrRS, expressed in E. coli cells after induction by IPTG and containing a 6His-tag, has been performed by metal-chelation chromatography. According to gel-electrophoresis data, the homogeneity of recombinant protein was about 95 % [17] .
Since EMAP-2 cytokine has been shown to induce migration of monocytes and polymorphonuclear leukocytes in vitro [12, 18] , we therefore examined the effects of TyrRS C-domain on monocyte migration, using a micro-chemotaxis chamber assay. The addition of Ty rRS C-doniain to the lower chamber led to a ~ 2-fold enhancement of monocyte migration (Fig. 1) . Monocyte migration was induced by Cdomain in the range I pM-10 nM (between 1 ρ M and 100 pM this increase was significant, p< 0.05) at levels slightly greater than that induced by recombinant EMAP-2 over a similar concentration range, but not as high as those achieved with 10 nM control chemotactic peptide fMLP. In contrast to isolated C-domain, the truncated 39K form of mammalian TyrRS, which lacks this domain, did not affect monocyte migration (Fig. 1) .
A defining biological activity of EMAP-2 is its ability to induce tissue-factor-dependent procoagulant activity on the surface of endothelial cells in vitro, and furthermore to potentiate procoagulant activiity induced by tumour necrosis factor (TNF) in vitro (12] . Therefore we studied the abilities of TyrRS C-domain and EMAP-2 polypeptide to induce tissue factormediated procoagulant activity on the surface of cultured HUV EC.
The exposure of endothelial cells to isolated C-domain for 4 hr at concentrations of 1 -KM) pM led to a dose-dependent increase in cell surface tissue factor between 0,36 and 0.77 pg TFE/IO 6 cells on endothelial cells (Fig. 2, a) . EMAP-2 also induced the enhancement of tissue factor activity in a dose-dependent manner (Fig. 2, b) , but maximum activity was observed at lower mediator concentration at about 1 pM.
Our data suggest that the isolated C-domain of mammalian TyrRS reveals cytokine-like activities both as a chemotactic factor for monocytes and as an inducer of tissue factor expression on human endothelial cells similar to EMAP-2 cytokine. We propose, therefore, that the C-domain of TyrRS could potentially mimic the action of EMAP-2 cytokine through the interactions with complementary sites on the specific receptor.
Moreover, the cellular effects of TyrRS C-domain that we have observed, in particular the induction of tissue factor activity, cannot be fully explained by an interaction of its N-terminal region with a receptor. As indicated earlier, the chemotactic and tissue factor-inducing activity of EMAP-2 are believed to reside within different regions of the molecule [14] . Since we have also observed tissue factor induction in response to the TyrRS C-domain, it is possible that other functional domains of this C-terminal module, except its N-terminal region, could be involved in its cytokine activities.
If the EMAP-2-Ике domain of TyrRS is released 
. Induction of procoagulant activity of tissue factor in human endothelial cells by recombinant C-domain of TyrRS (A) or EMAP-2 cytokine (B). Results are the means of 6 replicates pooled from 2 separate experiments
after proteolytic cleavage at the loop, connecting the catalytic 39 kDa enzyme core and this C-domain, it could be involved as a mediator in signal transduction process through the interactions with a putative EMAP-2 receptor. The nature of the EMAP-2 receptor is not known, although cross-linking studies have demonstrated binding of EMAP-2-derived peptides to a 73K protein associated with the monocyte cell surface [21 ] , suggesting the existence of a distinct receptor.
Recently, it was shown that in cultured cells post-translatiorial processing of proEMAP-2 into mature cytokine EMAP-2 occurred coincidentally with apoptosis programmed cell death [22 ] . It is well known that during apoptosis process some proteases, e. g. interleukin-1 converting enzyme (ICE, caspase) are activated [22] . It is possible to propose, that mammalian TyrRS could be cleaved during apoptotis proteolytic cascade, or other protease activation process.
It is interesting to note, that other component of protein biosynthesis machinery, auxiliary p43 protein of multi-synthetase complex, is proposed to be a precursor of EMAP-2 cytokine [23 ] .
Our results suggest a novel non-canonical function of mammalian aminoacyl-tRNA synthetases in higher eukaryotic cells, which may be associated with signal transduction process. Furthermore this function may only be expressed in conditions where cellular proteases are activated. 
